TransThera Sciences (Nanjing) Inc.
Status: Publicly traded
Direct answer
TransThera Sciences (Nanjing) Inc. is publicly traded on HKSE under the ticker 2617.HK.
TransThera Sciences (Nanjing) Inc. operates as a clinical-stage biopharmaceutical firm, dedicated to the discovery, advancement, and marketing of small-molecule treatments. Their therapeutic focus spans oncology (cancer), inflammatory conditions, and cardiometabolic disorders. The company's portfolio notably includes Tinengotinib (TT-00420), an MTK inhibitor designed to address drug-resistant, recurrent, or...
Can you invest in TransThera Sciences (Nanjing) Inc.?
Yes. TransThera Sciences (Nanjing) Inc. is publicly traded on HKSE under the ticker 2617.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for TransThera Sciences (Nanjing) Inc.
Detailed equity research is provided by MarketSnap.